The Wayback Machine - http://web.archive.org/web/20260219152202/https://finance.yahoo.com/sectors/healthcare/
Healthcare
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.
Market Cap
7.588T
Market Weight
9.71%
Industries
11
Companies
1136
Healthcare S&P 500 ^GSPC
Chart Range Bar
Loading chart for Healthcare

Day Return

Sector
0.60%
S&P 500
0.24%

YTD Return

Sector
4.86%
S&P 500
0.46%

1-Year Return

Sector
13.60%
S&P 500
12.00%

3-Year Return

Sector
21.29%
S&P 500
68.29%

5-Year Return

Sector
26.15%
S&P 500
75.72%

Note: Sector performance is calculated based on the previous closing price of all sector constituents

Industries in This Sector

Select an Industry for a Visual Breakdown

IndustryMarket WeightYTD Return
All Industries
100.00%
4.86%
Drug Manufacturers - General
42.35%
17.56%
Biotechnology
12.21%
0.85%
Medical Devices
11.45%
-0.82%
Diagnostics & Research
9.54%
-7.43%
Healthcare Plans
7.56%
-7.88%
Medical Instruments & Supplies
6.68%
-3.47%
Medical Distribution
3.29%
10.37%
Medical Care Facilities
3.21%
10.74%
Drug Manufacturers - Specialty & Generic
2.57%
1.94%
Health Information Services
1.14%
-38.47%
Pharmaceutical Retailers
0.00%
-16.09%

Note: Percentage % data on heatmap indicates Day Return

All Industries

Drug Manufacturers - General
-0.76%
Biotechnology
-0.89%
Medical Devices
-0.39%
Diagnostics & Research
-0.78%
Healthcare Plans
-0.22%
Medical Instruments & Supplies
-0.18%
Medical Distribution
-0.20%
Medical Care Facilities
-0.54%
Drug Manufacturers - Specialty & Generic
-0.11%
Health Information Services
0.71%
Pharmaceutical Retailers
-0.83%

<= -3

-2

-1

0

1

2

>= 3

Largest Companies in This Sector

View More
Table View
Heatmap View
Name
Last Price
1Y Target Est.
Market Weight
Market Cap
Day Change %
YTD Return
Avg. Analyst Rating
1,013.83 1,202.37 13.18% 956.403B -0.66% -5.66%
Buy
244.95 231.25 8.14% 590.305B -0.02% +18.36%
Buy
225.98 246.63 5.51% 399.394B -1.20% -1.10%
Buy
121.10 124.89 4.17% 302.482B -0.46% +15.05%
Buy
287.85 364.62 3.59% 260.746B -0.12% -12.80%
Buy
376.94 350.04 2.80% 203.173B -0.73% +15.16%
Buy
112.66 133.39 2.70% 196.08B -0.56% -10.08%
Buy
509.61 666.46 2.64% 191.463B -0.77% -12.05%
Buy
151.59 155.42 2.59% 188.072B -0.75% +23.50%
Buy
501.60 611.82 2.46% 178.133B +0.17% -11.43%
Buy

Investing in the Healthcare Sector

Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds

ETF Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
156.78 40.98B 0.08% +1.28%
289.50 19.812B 0.09% +0.57%
173.13 8.534B 0.44% +2.58%
124.66 8.336B 0.35% +2.24%
100.38 4.621B 0.40% +3.06%

Mutual Fund Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
209.40 39.263B 0.32% +2.36%
88.29 39.263B 0.32% +2.37%
145.79 19.812B 0.09% +1.29%
134.20 15.226B 0.00% +0.74%
11.18 15.226B 0.00% +0.66%

Healthcare Research

View More

Discover the Latest Analyst and Technical Research for This Sector

  • Analyst Report: Gilead Sciences, Inc.

    Gilead Sciences is a biopharmaceutical company that researches, develops, and sells therapies for treating HIV, hepatitis B, hepatitis C, and certain cancers. In October 2020, Gilead's Veklury (remdesivir) became the first approved treatment for COVID-19 in the U.S. Founded in 1987, the company is based in Foster City, California. It has operations in more than 40 countries and more than 18,000 employees.

    Rating
    Price Target
     
  • Market Digest: GILD, NJR, XYL, TWLO, FOXA

    We've used this space to highlight cautious insider sentiment so far in 2026, this based on weekly data from Vickers Stock Research. While the stock market has been volatile, the past 30 days have left the S&P 500 off 0.85%, the Nasdaq down 3.2%, and the DJIA up 0.61%. Turning to the broad insider-sentiment indicators from Vickers, the NYSE Eight-Week Sell/Buy is worse this week than last, at 5.61, and just below the bearish zone that runs from 6.0 and up. The Nasdaq eight-week ratio is a little better this week at 6.09, but remains bearish. And finally, the Total (all exchanges) ratio is flat week over week at a neutral, but almost bearish, 5.77. Things get interesting when we look at Vickers' sector sell/buy ratios. Energy, the top-performing sector year to date according to Bloomberg, now logs a neutral eight-week ratio, having been bullish. Are Energy insiders starting to take profits? Meanwhile, Financial, Bloomberg's worst-performer, sports a bullish ratio (and has for a few weeks now). Are Financial insiders seeing value? And finally, Information Technology, also a bottom-of-the-list performer, had Vickers' only bearish ratio for the past several weeks. But this week, it has improved to neutral. Perhaps these insiders are starting to see a light at the end of the sector tunnel. From a shorter-term sector perspective, only one sector delivered a bullish one-week sell/buy ratio this week: Healthcare. Last week, the sector rang in at neutral. This week, analysts at Vickers highlighted insider transactions of interest at Delta Air Lines Inc. (NYSE: DAL) and Cleveland-Cliffs Inc. (NYSE: CLF).

     
  • Daily – Vickers Top Insider Picks for 02/19/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     
  • Daily – Vickers Top Buyers & Sellers for 02/19/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     

From the Community

Healthcare News